Droplet Method for Bilayer Assays

双层测定的液滴法

• 批准号: 7660234
• 负责人: GREGORY W FARIS
• 金额: $ 21.83万
• 依托单位: SRI INTERNATIONAL
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-08 至 2011-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7660234
• 关键词: Address; Affect; Area; Artificial Membranes; Binding; Biological Assay; Cells; Controlled Study; Data; Development; Disease; Emulsions; Fluorescent Dyes; Health; Hereditary Disease; Human; Human body; Image; Individual; Infection; Integral Membrane Protein; Lasers; Lead; Lipid Bilayers; Lipids; Liposomes; Malignant Neoplasms; Medical Research; Membrane; Membrane Lipids; Membrane Proteins; Methods; Molecular Bank; Optics; Peptides; Performance; Permeability; Pharmaceutical Preparations; Phase; Property; Proteins; Public Sector; Publications; Reagent; Research; Side; Signal Transduction; Solid; Surface; Techniques; Testing; Transport Process; United States National Institutes of Health; Vesicle; aqueous; base; drug testing; flexibility; high throughput screening; interfacial; protein function; public health relevance; small molecule

DESCRIPTION (provided by applicant): Membrane proteins are extremely important to understanding human health and treating disease. They make up 30% of all proteins in the body, are involved in regulating signal transduction and molecular transport into and between cells, and are the target of most drugs available today. To function properly, membrane proteins must be embedded in a lipid membrane layer. Well-controlled studies of individual membrane proteins require creating an artificial membrane to hold the protein, but existing methods for producing artificial membranes, such as the black lipid membrane and membranes with solid support, cannot be adapted to high- throughput techniques because the membranes are quite delicate for black lipid membranes or have limited access for membranes with solid support. High-throughput methods, which allow examination of a large number of compounds or a large number of interactions simultaneously, are increasingly being used to study molecular interactions affecting human health and to identify and test drugs. The importance of high- throughput screening has been recognized in the NIH Roadmap for Medical Research. The Molecular Libraries and Imaging portion of the NIH Roadmap seeks to facilitate the development of new, small-molecule drugs within the public sector. High-throughput screening of these small molecules is an integral part of the proposed effort. We propose to investigate a method for studying lipid membranes and membrane proteins based on an inverted emulsion. With this method we can readily produce bilayer membranes with small volumes and small surface areas. We expect that this method will be easily adapted to high-throughput screening of membrane protein function and drugs influencing membrane proteins. Because of the small size of the membrane, this technique will avoid the membrane fragility issues typical of black lipid membrane techniques. Furthermore, because the membrane is formed between two inverted emulsion droplets, we will avoid the difficulties in accessing both sides of the membrane found with artificial membranes on solid support. With the small volumes involved, we can minimize the quantities of reagent used in assays and can perform very large numbers of assays rapidly on a single substrate. We propose to investigate the inverted emulsion method for membrane proteins by: (1) studying bilayer formation in an inverted emulsions by characterizing the bilayer performance with respect to the continuous phase and lipid composition and phase of introduction, and comparing the membrane properties with liposomes through permeability studies; and (2) testing membrane performance using inserted proteins or peptides. We will incorporate one transmembrane protein and one self- assembled pore with a transmembrane peptide into the interfacial bilayer and use fluorescent dyes to establish their presence and function. PUBLIC HEALTH RELEVANCE: PROJECT NARRATIVE Transmembrane proteins are a very important class of molecules in the human body and are the target of most drugs available today. This research develops a powerful new method for studying the function of transmembrane proteins that should in turn lead to improvements in treating a wide range of diseases ranging from infections to cancer to genetic disorders.

描述（由申请人提供）：膜蛋白对了解人类健康和治疗疾病极其重要。它们占体内所有蛋白质的30%，参与调节信号转导和细胞内及细胞间的分子运输，是当今大多数可用药物的靶标。为了正常工作，膜蛋白必须嵌入脂质膜层。对单个膜蛋白的控制良好的研究需要创造一个人工膜来容纳蛋白质，但是现有的生产人工膜的方法，如黑脂膜和固体支持膜，不能适应高通量技术，因为膜对黑脂膜来说非常微妙，或者对固体支持膜的接触有限。高通量方法允许同时检查大量化合物或大量相互作用，正越来越多地用于研究影响人类健康的分子相互作用以及识别和测试药物。高通量筛选的重要性已在美国国立卫生研究院医学研究路线图中得到认可。美国国立卫生研究院路线图的分子文库和成像部分旨在促进公共部门内新的小分子药物的开发。这些小分子的高通量筛选是拟议努力的一个组成部分。我们提出了一种基于倒置乳状液的研究脂质膜和膜蛋白的方法。用这种方法，我们可以很容易地生产小体积和小表面积的双层膜。我们期望这种方法能够很容易地适应于高通量筛选膜蛋白功能和影响膜蛋白的药物。由于膜的尺寸小，这种技术将避免典型的黑脂膜技术的膜脆性问题。此外，由于膜是在两个倒置的乳状液滴之间形成的，我们将避免在固体支撑上使用人工膜时难以进入膜的两侧。由于涉及的体积小，我们可以最大限度地减少测定中使用的试剂数量，并且可以在单一底物上快速进行大量测定。我们建议通过以下方法来研究膜蛋白的反乳方法：(1)通过表征双分子层在连续相和脂质组成和引入相方面的性能来研究反分子层在反分子乳中的形成，并通过渗透性研究将膜性质与脂质体进行比较；(2)利用插入的蛋白质或多肽检测膜的性能。我们将一个跨膜蛋白和一个带有跨膜肽的自组装孔整合到界面双分子层中，并使用荧光染料来确定它们的存在和功能。跨膜蛋白是人体中一类非常重要的分子，也是当今大多数可用药物的靶标。这项研究开发了一种强大的新方法来研究跨膜蛋白的功能，这反过来将导致治疗从感染到癌症到遗传疾病的广泛疾病的改进。